WallStreetZen

AnalystsAlethia Young
Alethia Young's Stock Forecasts

Ranking
Top 2%
#52 out of 3515 analysts
Average Return
+34.77%
Win Rate
54%44 out of 81
Risk vs Reward
Poor
Good

Alethia Young's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Pacific Biosciences Of California IncPACB
+781.46%$3.56$31.38
2020-03-09 -
2021-03-09
Strong Buy
Curis IncCRIS
+479.03%$1.24$7.18
2020-07-17 -
2021-07-16
Strong Buy
Anaptysbio IncANAB
+260.34%$23.85$85.94
2017-08-25 -
2018-08-24
Buy
Sarepta Therapeutics IncSRPT
+214.48%$45.38$142.71
2017-09-07 -
2018-09-07
Buy
Ra Pharmaceuticals IncRARX
+206.85%$10.07$30.90
2018-08-07 -
2019-08-07
Buy

Alethia Young's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Adverum Biotechnologies IncADVM
2Hold$3.00-24.33%Downgrades
9 days ago
RAPT Therapeutics IncRAPT
1Strong Buy$71.00-56.80%Maintains
2 months ago
Vertex Pharmaceuticals IncVRTX
3Strong Buy$281.00-28.26%Maintains
2 months ago
Provention Bio IncPRVB
2Strong Buy$25.00-75.72%Maintains
4 months ago
Longboard Pharmaceuticals IncLBPH
1Strong Buy$32.00-71.88%Initiates Coverage On
4 months ago
Eledon Pharmaceuticals IncELDN
1Strong Buy$25.00-74.04%Initiates Coverage On
4 months ago
NexImmune IncNEXI
1Strong Buy$35.00-69.49%Initiates Coverage On
5 months ago
Akebia Therapeutics IncAKBA
1Strong Buy$8.00-69.13%Initiates Coverage On
5 months ago
Arena Pharmaceuticals IncARNA
3Strong Buy$100.00-38.14%Maintains
5 months ago
Fate Therapeutics IncFATE
1Strong Buy$98.00-15.51%Maintains
5 months ago
Biogen IncBIIB
3Hold$268.00+21.91%Maintains
5 months ago
Regeneron Pharmaceuticals IncREGN
2Strong Buy$656.00-12.41%Maintains
6 months ago
Amgen IncAMGN
6Strong Buy$295.00-18.12%Maintains
6 months ago
BICYCLE THERAPEUTICS plcBCYC
1Strong Buy$30.00+5.33%Initiates Coverage On
10 months ago
Gilead Sciences IncGILD
2Strong Buy$84.00-18.70%Maintains
a year ago
Alx Oncology Holdings IncALXO
1Strong Buy$64.00-8.50%Initiates Coverage On
a year ago
Curis IncCRIS
1Strong Buy$4.00N/AInitiates Coverage On
a year ago
Intercept Pharmaceuticals IncICPT
1HoldN/AN/ADowngrades
a year ago
Tg Therapeutics IncTGTX
1Strong Buy$35.00N/AMaintains
a year ago
Marinus Pharmaceuticals IncMRNS
1Strong Buy$6.00N/AReiterates
a year ago
Stemline Therapeutics IncSTML
2Hold$12.50N/ADowngrades
a year ago
Ascendis Pharma AASND
5Strong Buy$201.00N/AReiterates
a year ago
Arrowhead Pharmaceuticals IncARWR
2Strong Buy$60.00N/AUpgrades
a year ago
Ptc Therapeutics IncPTCT
3Strong Buy$85.00N/AReiterates
a year ago
Arcus Biosciences IncRCUS
1Strong Buy$21.00N/AInitiates Coverage On
a year ago
Pacific Biosciences Of California IncPACB
1Strong Buy$5.00N/AAssumes
a year ago
Aurinia Pharmaceuticals IncAUPH
1Strong Buy$32.00N/AMaintains
a year ago
Verastem IncVSTM
1Strong Buy$6.00N/AMaintains
a year ago
Sarepta Therapeutics IncSRPT
6Strong Buy$217.00N/AReiterates
a year ago
Agios Pharmaceuticals IncAGIO
4Strong Buy$70.00N/AReiterates
a year ago
Incyte CorpINCY
2Hold$65.00N/AMaintains
2 years ago
Spectrum Pharmaceuticals IncSPPI
1Hold$4.00N/ADowngrades
2 years ago
Ra Pharmaceuticals IncRARX
3Buy$17.00N/AMaintains
3 years ago
Anaptysbio IncANAB
2Buy$104.00N/AInitiates Coverage On
3 years ago
Alexion Pharmaceuticals IncALXN
3Buy$154.00N/AMaintains
3 years ago
TESARO IncTSRO
3Buy$128.00N/AMaintains
3 years ago
Mesoblast LtdMESO
1SellN/AN/ADowngrades
3 years ago
Alnylam Pharmaceuticals IncALNY
3Buy$154.00N/AMaintains
3 years ago
Biomarin Pharmaceutical IncBMRN
2Buy$116.00N/AMaintains
3 years ago
Celgene CorpCELG
1Buy$129.00N/AMaintains
3 years ago
Amerisourcebergen CorpABC
1Buy$112.00N/AMaintains
3 years ago
Puma Biotechnology IncPBYI
4Buy$106.00N/AMaintains
4 years ago
Bioverativ IncBIVV
3Hold$105.00N/AMaintains
4 years ago
Acceleron Pharma IncXLRN
1Buy$51.00N/AMaintains
4 years ago
Intellia Therapeutics IncNTLA
1Buy$28.00N/AMaintains
4 years ago
Darden Restaurants IncDRI
1Hold$82.00N/AMaintains
4 years ago
UNITED THERAPEUTICS CorpUTHR
1SellN/AN/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.